i-Women Health 2024 will provide an opportunity for the participating companies to display their products & services to the gamut of visitors, globally from healthcare industries. The program is directed at obstetricians, gynecologists, midwives, general practitioners, and other specialists working in the field of women’s health, policy and decision-makers, patient groups, business professionals, manufacturers, and leaders from the healthcare industry who are planning to expand their business through various channels of franchise and distribution. i-Women Health aims to achieve the highest possible standards of physical, mental, reproductive, and sexual health and wellbeing throughout their lives, and to preserve and improve women’s and sexual rights.
For more details & price quotation contact firstname.lastname@example.org
Download Exhibitor-Sponsor Catalog from below
Women’s health is a perspective of diagnosis, treatment, and prevention of health concerns among females. There have been major changes in private and government support of women’s health research - in regulations, policies, and the organization of research efforts. Research in the field of Women’s health has contributed to consequential progress over the past 20 years in lessening the burden of disease and reducing deaths from some conditions for women.
In both developed and developing countries, breast cancer is the most common cancer among women. The growing number of cases of breast cancer is linked to early menarche, excessive exposure to endogenous estrogens, late menopause, and late stage at first childbirth which all are anticipated to render high impact on the market growth. While prevention can reduce risk, it would not be enough to eradicate the majority of breast cancers that arise in low- and middle-income countries, where breast cancer is diagnosed at an advanced stage. As a result, early detection remains the cornerstone of breast cancer prevention enhance breast cancer outcome and survival.
The global women’s health market has been growing at a remarkable pace in the past few years. The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 at a CAGR of around 7.9 %. Changing lifestyles, increasing the prevalence of cancer among women and poor dietary habits, growing awareness about various health-related disorders, rising incidence of various chronic disorders, and high prevalence of infectious diseases such as HIV and hepatitis in women across the globe are expected to make a significant contribution to the soaring revenue of the overall market. An increase in the geriatric female population and economic growth are also likely to generate large opportunities in the women’s health market. The global women’s health industry is witnessing an increasing number of acquisitions, product launches, and alliances such as partnerships, agreements, and collaborations between players offering better women health diagnostics solutions.
Get involved with us along with other related industry experts and stay ahead of the curve. No matter how large or small your marketing budget, you'll benefit from significant sources of visibility from these opportunities.